Crossroads utilizes an innovative new Medication-Assisted Treatment approach in the residential, intensive outpatient and outpatient treatment settings to help increase sobriety and reduce relapse. This cutting edge treatment approach is the sought after standard of best practice in substance abuse programming. Our board-certified addictionologist and psychiatrist provides this highly specialized, clinically proven and individualized service in combination with counseling and behavioral therapies to more effectively treat substance-use disorders.
Medication-Assisted Treatment refers to the prescription of typically one of six medications (Vivitrol, Revia (Naltrexone), Antabuse, Neurontin, Topamax, and Campral) all of which have been FDA-approved and demonstrated to treat prescription, illicit drug dependence or alcoholism. Each drug is unique and allows the choice of individually tailoring the medication assistance to the patient. Medication-Assisted Treatment (MAT) provides a whole-patient approach to the treatment of substance use disorders.
There is substantial scientific evidence supporting the fact that MAT significantly improves success rates in the first six months of recovery. MAT is clinically driven with a focus on individualized patient care. Currently, very few substance abuse recovery programs include this kind of treatment and those that do will both enhance recovery and produce documentable objective evidence of success.
Early Treatment Onset and Average Medication-Assisted Treatment Length
The critical time to begin these medications is the first six months of recovery. Those who make it through this period sober have a good chance at long term success. Medication-Assisted Treatment has been shown to definitively increase the percent of people who maintain abstinence during this critical period. Therefore, the ideal time to start these medications is after Detox, during the second and third week of residential rehab, or from intensive outpatient or outpatient services in select cases.
The prescription of these medications will continue usually for 6 to 12 months while the person is finished with their formal treatment plan, but attending twelve step meetings.
Integrated Medical Monitoring
Crossroads integrates the highest level of available medical monitoring together with Medication-Assisted Treatment in order to improve the success of the program outcomes for individuals served. Quality, credentialed, and advanced drug screening completed by a nationally accredited laboratory, along with specialized ongoing evaluation by trained professional medical and clinical staff is provided through Crossroads. Addiction Medicine Evaluations with our Board Certified Addictionologist are integrated along with psychosocial treatment programming in order to enhance the client’s treatment and provide the greatest opportunity for long term success. These enhanced and coordinated services set the Crossroads program apart from other programs in terms of reliability and objective documentation, as well as the percentage of people who are actually abstinent at the completion their program.